Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
06/11/2013
06/11/2013
2012
|
Resumo |
A growing body of evidence indicates that facilitation of serotonin-2C receptor (5-HT2CR)-mediated neurotransmission in the basolateral nucleus of the amygdala (BLA) is involved in anxiety generation. We investigated here whether BLA 5-HT(2C)Rs exert a differential role in the regulation of defensive behaviours related to generalized anxiety (inhibitory avoidance) and panic (escape) disorders. We also evaluated whether activation of BLA 5-HT(2C)Rs accounts for the anxiogenic effect caused by acute systemic administration of the antidepressants imipramine and fluoxetine. Male Wistar rats were tested in the elevated T-maze after intra-BLA injection of the endogenous agonist 5-HT, the 5-HT2CR agonist MK-212 or the 5-HT2CR antagonist SB-242084. This test allows the measurement of inhibitory avoidance acquisition and escape expression. We also investigated whether intra-BLA administration of SB-242084 interferes with the acute anxiogenic effect caused by imipramine and fluoxetine in the Vogel conflict test, and imipramine in the elevated T-maze. While intra-BLA administration of 5-HT and MK-212 facilitated inhibitory avoidance acquisition, suggesting an anxiogenic effect, SB-242084 had the opposite effect. None of these drugs affected escape performance. Intra-BLA injection of a sub-effective dose of SB-242084 fully blocked the anxiogenic effect caused either by the local microinjection of 5-HT or the systemic administration of imipramine and fluoxetine. Our findings indicate that 5-HT(2C)Rs in BLA are selectively involved in the regulation of defensive behaviours associated with generalized anxiety, but not panic. The results also provide the first direct evidence that activation of BLA 5-HT(2C)Rs accounts for the short-term aversive effect of antidepressants. FAPESP CNPq (Brazil) |
Identificador |
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, NEW YORK, v. 15, n. 3, pp. 389-400, APR, 2012 1461-1457 http://www.producao.usp.br/handle/BDPI/42414 10.1017/S1461145711000873 |
Idioma(s) |
eng |
Publicador |
CAMBRIDGE UNIV PRESS NEW YORK |
Relação |
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY |
Direitos |
closedAccess Copyright CAMBRIDGE UNIV PRESS |
Palavras-Chave | #ANTIDEPRESSANT #ANXIETY #BASOLATERAL AMYGDALA #SEROTONIN #ELEVATED T-MAZE #DORSAL PERIAQUEDUCTAL GRAY #ANXIETY-LIKE BEHAVIOR #5-HT2C RECEPTOR #REUPTAKE INHIBITORS #PLUS-MAZE #ANXIOUS STATES #ANIMAL-MODELS #DOUBLE-BLIND #IN-VIVO #CLINICAL NEUROLOGY #NEUROSCIENCES #PHARMACOLOGY & PHARMACY #PSYCHIATRY |
Tipo |
article original article publishedVersion |